Who may qualify
- Individuals prescribed Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity
- Users who developed a serious gastrointestinal condition during or after use
- Individuals hospitalized or requiring surgery for a covered condition
Practice area
Ozempic & GLP-1 Drug Lawsuits
Educational overview of lawsuits involving GLP-1 receptor agonists such as Ozempic, Wegovy, Mounjaro, and Rybelsus, and alleged serious gastrointestinal side effects.
Start free eligibility review Last updated July 1, 2026
Listen to this section
1.00x
GLP-1 receptor agonists are widely prescribed for type 2 diabetes and, in some cases, for weight management. Lawsuits allege that certain manufacturers failed to adequately warn about the risk of severe gastrointestinal side effects.
Cases are consolidated in the federal GLP-1 MDL. Eligibility depends on the specific product used, duration of use, and documented diagnosis.
Alleged injuries under review
- Gastroparesis (stomach paralysis)
- Severe or cyclical vomiting
- Intestinal obstruction or ileus
- Gallbladder disease requiring surgery
- Other conditions under attorney review
Litigation status
The GLP-1 MDL is in active discovery. No global settlement has been announced. Bellwether case selection is ongoing.
This section is updated periodically for educational purposes. Nothing here is legal advice, and nothing implies a guarantee of eligibility or outcome.
Helpful documents
- Pharmacy records confirming prescription and dates
- Medical records confirming the diagnosis
- Hospitalization or surgical records, if applicable
- List of any other medications used during the same period
Frequently asked questions
I lost weight on Ozempic — is that a claim?+
No. These lawsuits focus on serious diagnosed gastrointestinal injuries, not weight-loss outcomes or common, expected side effects.
Do I need a formal gastroparesis diagnosis?+
In most cases yes — attorneys typically look for a documented diagnosis (often via gastric emptying study) or a hospitalization for a covered condition.
Is Ozempic being recalled?+
No. The medication remains on the market. These are civil claims about alleged failure to warn, not a recall action.
See if your situation qualifies for review.
Submitting an inquiry is free and confidential. There is no obligation, and no attorney-client relationship is created by contacting The Claim Desk.
The Claim Desk is not a law firm and does not provide legal advice. Content on this page is educational and does not constitute a promise of eligibility, representation, or compensation. Case results depend on the unique facts of each matter.